REGISTERED
on 26 Jul 2022
Last Applicant/ Owned by
155 Franklin Road, Suite 450
Brentwood
TN
37027
Serial Number
88404065 filed on 26th Apr 2019
Registration Number
6804470 registered on 26th Jul 2022
Correspondent Address
Andrew N. Spivak
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CURRAX PHARMACEUTICALS LLC
Pharmaceutical preparations for use in connection with humans for treatment of disorders, diseases and conditions of the endocrinology, cardiology, neurology, gastroenterology, pulmonary, and immune systems and for treatment of metabolic and psychiatric disorders, diseases and conditions
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in connection with humans for treatment of disorders, diseases and conditions of the endocrinology, cardiology, neurology, gastroenterology, pulmonary, and immune systems and for treatment of metabolic and psychiatric disorders, diseases and conditions
First Use Date in General
15th Apr 2019
First Use Date in Commerce
01st May 2019
Mark Details
Serial Number
No 88404065
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.07.14 -
Three diamonds
26.07.21 -
Diamonds that are completely or partially shaded
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Jul 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 26th Jul 2022 | REGISTERED-PRINCIPAL REGISTER |
| 21st Jun 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 19th Jun 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 16th Jun 2022 | EXAMINER'S AMENDMENT ENTERED |
| 15th Jun 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 15th Jun 2022 | EXAMINERS AMENDMENT E-MAILED |
| 15th Jun 2022 | SU-EXAMINER'S AMENDMENT WRITTEN |
| 24th May 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 24th May 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |